TRAVERE THERAPEUTICS, INC. Other Noncash Income (Expense)
TRAVERE THERAPEUTICS, INC. (TVTX) reported Other Noncash Income (Expense) of $2.61 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-08-04
- TRAVERE THERAPEUTICS, INC. other noncash income (expense) for the quarter ending 2026-06-30 was $2.61M.
- TRAVERE THERAPEUTICS, INC. other noncash income (expense) for the quarter ending 2026-03-31 was $4.00K, a 99.75% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. other noncash income (expense) for the quarter ending 2025-12-31 was -$43.00K.
- TRAVERE THERAPEUTICS, INC. other noncash income (expense) for the quarter ending 2025-09-30 was $807.00K, a 146.04% increase year-over-year.
- TRAVERE THERAPEUTICS, INC. other noncash income (expense) for fiscal 2025 was $1.46M.
- TRAVERE THERAPEUTICS, INC. other noncash income (expense) for fiscal 2024 was -$7.94M, a 319.08% decline from fiscal 2023.
- TRAVERE THERAPEUTICS, INC. other noncash income (expense) for fiscal 2023 was $3.63M.
- TRAVERE THERAPEUTICS, INC. other noncash income (expense) for fiscal 2022 was -$1.35M.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 3 month as first filed | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 6 month as first filed | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 9 month as first filed | Other Noncash Income (Expense) 12 month | Other Noncash Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $2.61M 10-Q · filed 2026-08-04 | $2.57M derived: sum of 3 quarters · filed 2026-08-04 | $3.38M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $4.00K 10-Q · filed 2026-05-04 | -$39.00K derived: sum of 2 quarters · filed 2026-05-04 | $768.00K derived: sum of 3 quarters · filed 2026-05-04 | -$108.00K derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | -$43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $764.00K derived: sum of 2 quarters · filed 2026-02-19 | -$112.00K derived: sum of 3 quarters · filed 2026-08-04 | $1.46M 10-K · filed 2026-02-19 | ||||
| 2025-09-30 | $807.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$69.00K derived: sum of 2 quarters · filed 2026-08-04 | $1.50M 10-Q · filed 2025-10-30 | -$1.42M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | -$876.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $693.00K 10-Q · filed 2026-08-04 | -$2.23M derived: sum of 3 quarters · filed 2026-08-04 | -$1.90M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $1.57M 10-Q · filed 2026-05-04 | -$1.35M derived: sum of 2 quarters · filed 2026-05-04 | -$1.02M derived: sum of 3 quarters · filed 2026-05-04 | -$6.01M derived: sum of 4 quarters · filed 2026-05-04 | ||||
| 2024-12-31 | -$2.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$2.59M derived: sum of 2 quarters · filed 2026-02-19 | -$7.58M derived: sum of 3 quarters · filed 2026-02-19 | -$7.94M 10-K · filed 2026-02-19 | ||||
| 2024-09-30 | $328.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$4.66M derived: sum of 2 quarters · filed 2025-10-30 | -$5.02M 10-Q · filed 2025-10-30 | -$7.21M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-06-30 | -$4.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$5.35M 10-Q · filed 2025-08-06 | -$7.54M derived: sum of 3 quarters · filed 2026-02-19 | -$4.45M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-03-31 | -$364.00K 10-Q · filed 2025-05-01 | -$2.55M derived: sum of 2 quarters · filed 2026-02-19 | $535.00K derived: sum of 3 quarters · filed 2026-02-19 | $2.17M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2023-12-31 | -$2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $899.00K derived: sum of 2 quarters · filed 2026-02-19 | $2.53M derived: sum of 3 quarters · filed 2026-02-19 | $3.63M 10-K · filed 2026-02-19 | ||||
| 2023-09-30 | $3.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $4.72M derived: sum of 2 quarters · filed 2024-10-31 | $5.82M 10-Q · filed 2024-10-31 | $634.00K 10-Q · filed 2023-11-07 | $9.85M derived: sum of 4 quarters · filed 2025-02-21 | |||
| 2023-06-30 | $1.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $2.73M 10-Q · filed 2024-08-01 | -$1.37M 10-Q · filed 2023-08-03 | $6.76M derived: sum of 3 quarters · filed 2025-02-21 | $5.36M derived: sum of 4 quarters · filed 2025-02-21 | |||
| 2023-03-31 | $1.10M 10-Q · filed 2024-05-06 | $488.00K 10-Q · filed 2023-05-04 | $5.13M derived: sum of 2 quarters · filed 2025-02-21 | $3.73M derived: sum of 3 quarters · filed 2025-02-21 | $1.86M derived: sum of 4 quarters · filed 2025-02-21 | |||
| 2022-12-31 | $4.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $2.63M derived: sum of 2 quarters · filed 2025-02-21 | $766.00K derived: sum of 3 quarters · filed 2025-02-21 | -$1.35M 10-K · filed 2025-02-21 | -$972.00K 10-K · filed 2023-02-23 | |||
| 2022-09-30 | -$1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$3.27M derived: sum of 2 quarters · filed 2023-11-07 | -$5.38M 10-Q · filed 2023-11-07 | -$3.66M 10-Q · filed 2022-10-27 | -$4.57M derived: sum of 4 quarters · filed 2024-02-20 | |||
| 2022-06-30 | -$1.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$3.98M 10-Q · filed 2023-08-03 | -$2.37M 10-Q · filed 2022-08-04 | -$3.17M derived: sum of 3 quarters · filed 2024-02-20 | -$4.97M derived: sum of 4 quarters · filed 2024-02-20 | |||
| 2022-03-31 | -$2.11M 10-Q · filed 2023-05-04 | -$152.00K 10-Q · filed 2022-05-05 | -$1.30M derived: sum of 2 quarters · filed 2024-02-20 | -$3.10M derived: sum of 3 quarters · filed 2024-02-20 | -$4.73M derived: sum of 4 quarters · filed 2024-02-20 | |||
| 2021-12-31 | $809.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | -$993.00K derived: sum of 2 quarters · filed 2024-02-20 | -$2.62M derived: sum of 3 quarters · filed 2024-02-20 | -$4.22M 10-K · filed 2024-02-20 | -$4.69M 10-K · filed 2022-02-24 | |||
| 2021-09-30 | -$1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | -$3.43M derived: sum of 2 quarters · filed 2022-10-27 | -$5.03M 10-Q · filed 2022-10-27 | -$2.62M 10-Q · filed 2021-10-29 | -$7.92M derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2021-06-30 | -$1.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$3.23M 10-Q · filed 2022-08-04 | -$1.81M 10-Q · filed 2021-07-29 | -$6.12M derived: sum of 3 quarters · filed 2023-02-23 | -$6.41M derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2021-03-31 | -$1.60M 10-Q · filed 2022-05-05 | -$375.00K 10-Q · filed 2021-05-06 | -$4.49M derived: sum of 2 quarters · filed 2023-02-23 | -$4.78M derived: sum of 3 quarters · filed 2023-02-23 | -$5.08M derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2020-12-31 | -$2.89M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$3.18M derived: sum of 2 quarters · filed 2023-02-23 | -$3.48M derived: sum of 3 quarters · filed 2023-02-23 | -$3.46M 10-K · filed 2023-02-23 | -$851.00K 10-K · filed 2021-03-01 | |||
| 2020-09-30 | -$289.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | -$588.00K derived: sum of 2 quarters · filed 2021-10-29 | -$563.00K 10-Q · filed 2021-10-29 | -$446.00K 10-Q · filed 2020-11-05 | -$2.15M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-06-30 | -$299.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$274.00K 10-Q · filed 2021-07-29 | -$496.00K 10-Q · filed 2020-07-31 | -$1.86M derived: sum of 3 quarters · filed 2022-02-24 | -$1.82M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-03-31 | $25.00K 10-Q · filed 2021-05-06 | -$1.56M derived: sum of 2 quarters · filed 2022-02-24 | -$1.52M derived: sum of 3 quarters · filed 2022-02-24 | -$1.51M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | -$1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$1.54M derived: sum of 2 quarters · filed 2022-02-24 | -$1.54M derived: sum of 3 quarters · filed 2022-02-24 | -$1.60M 10-K · filed 2022-02-24 | $51.00K 10-K · filed 2020-02-24 | |||
| 2019-09-30 | $45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $47.00K derived: sum of 2 quarters · filed 2020-11-05 | -$15.00K 10-Q · filed 2020-11-05 | $366.00K derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | -$60.00K 10-Q · filed 2020-07-31 | $321.00K derived: sum of 3 quarters · filed 2021-03-01 | $535.00K derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | -$62.00K 10-Q · filed 2020-05-11 | $319.00K derived: sum of 2 quarters · filed 2021-03-01 | $533.00K derived: sum of 3 quarters · filed 2021-03-01 | $409.00K derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | $381.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $595.00K derived: sum of 2 quarters · filed 2021-03-01 | $471.00K derived: sum of 3 quarters · filed 2021-03-01 | $396.00K 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | $214.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $90.00K derived: sum of 2 quarters · filed 2019-10-30 | $15.00K 10-Q · filed 2019-10-30 | $262.00K derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-06-30 | -$124.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$199.00K 10-Q · filed 2019-08-06 | -$537.00K 10-Q · filed 2018-08-03 | $48.00K derived: sum of 3 quarters · filed 2020-02-24 | $81.00K derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-03-31 | -$75.00K 10-Q · filed 2019-05-07 | $172.00K derived: sum of 2 quarters · filed 2020-02-24 | $205.00K derived: sum of 3 quarters · filed 2020-02-24 | $61.00K derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2017-12-31 | $247.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $280.00K derived: sum of 2 quarters · filed 2020-02-24 | $136.00K derived: sum of 3 quarters · filed 2020-02-24 | $83.00K 10-K · filed 2020-02-24 | -$526.00K 10-K · filed 2018-02-27 | |||
| 2017-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$111.00K derived: sum of 2 quarters · filed 2018-11-01 | -$164.00K 10-Q · filed 2018-11-01 | -$95.00K 10-Q · filed 2017-11-07 | -$229.00K derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-06-30 | -$144.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | -$197.00K 10-Q · filed 2018-08-03 | -$260.00K 10-Q · filed 2017-08-09 | -$262.00K derived: sum of 3 quarters · filed 2019-02-26 | -$251.00K derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-03-31 | -$53.00K 10-Q · filed 2018-07-06 | -$118.00K derived: sum of 2 quarters · filed 2019-02-26 | -$107.00K derived: sum of 3 quarters · filed 2019-02-26 | |||||
| 2016-12-31 | -$65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$54.00K derived: sum of 2 quarters · filed 2019-02-26 | -$54.00K 10-K · filed 2019-02-26 | |||||
| 2016-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $11.00K 10-Q · filed 2017-11-07 | ||||||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-09 | |||||||
| 2015-12-31 | -$405.00K 10-K · filed 2018-07-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |